Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts
- PMID: 1602555
- PMCID: PMC241258
- DOI: 10.1128/JVI.66.7.4488-4496.1992
Premature termination and processing of human immunodeficiency virus type 1-promoted transcripts
Abstract
We have used transient expression assays to study transcription directed by the human immunodeficiency virus (HIV) type 1 promoter. A plasmid containing an HIV-reporter gene fusion and a simian virus 40 origin of DNA replication was transfected into COS-1 cells in the presence or absence of a Tat expression vector. HIV-promoted RNA was analyzed by in vivo labeling, by RNase protection mapping, and in run-on transcription assays. As observed previously, two populations of HIV RNA accumulate in vivo: short, attenuated transcripts and long, polyadenylated mRNA. The short transcripts labeled in vivo were longer and more heterogeneous than expected from RNase protection assays. Moreover, comparison of transcripts labeled in vivo with run-on transcription products revealed that similar, if not identical, short RNAs accumulate in vitro. Utilizing the run-on assay, we show that following transcriptional termination, the attenuated transcripts undergo processing to generate one species of RNA. We also provide evidence that Tat does not act as an antiterminator to relieve a discrete elongation block but instead modifies transcriptional complexes, enabling them to overcome putative pause sites and continue transcription of the template.
Similar articles
-
In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions.Genes Dev. 1989 Mar;3(3):265-82. doi: 10.1101/gad.3.3.265. Genes Dev. 1989. PMID: 2542124
-
Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.J Mol Biol. 1995 Dec 1;254(3):350-63. doi: 10.1006/jmbi.1995.0622. J Mol Biol. 1995. PMID: 7490754
-
Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.Virology. 1997 Aug 18;235(1):48-64. doi: 10.1006/viro.1997.8672. Virology. 1997. PMID: 9300036
-
HIV trans-activation and transcription control mechanisms.New Biol. 1989 Nov;1(2):127-35. New Biol. 1989. PMID: 2562218 Review.
-
The regulation of human immunodeficiency virus type-1 gene expression.Eur J Biochem. 1996 Sep 15;240(3):491-507. doi: 10.1111/j.1432-1033.1996.0491h.x. Eur J Biochem. 1996. PMID: 8856047 Review.
Cited by
-
Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV).Plant Cell Rep. 2012 Mar;31(3):495-511. doi: 10.1007/s00299-011-1194-8. Epub 2011 Dec 13. Plant Cell Rep. 2012. PMID: 22159962 Review.
-
HIV Persistence, Latency, and Cure Approaches: Where Are We Now?Viruses. 2024 Jul 19;16(7):1163. doi: 10.3390/v16071163. Viruses. 2024. PMID: 39066325 Free PMC article. Review.
-
Regulation of host gene expression by HIV-1 TAR microRNAs.Retrovirology. 2013 Aug 12;10:86. doi: 10.1186/1742-4690-10-86. Retrovirology. 2013. PMID: 23938024 Free PMC article.
-
Regulation of eukaryotic gene expression by transcriptional attenuation.Mol Biol Cell. 1993 Jul;4(7):661-8. doi: 10.1091/mbc.4.7.661. Mol Biol Cell. 1993. PMID: 8400453 Free PMC article. Review. No abstract available.
-
Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors.Microbiol Rev. 1995 Sep;59(3):481-505. doi: 10.1128/mr.59.3.481-505.1995. Microbiol Rev. 1995. PMID: 7565415 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials